Lourdes M Perez-Chada,Joseph F Merola,April W Armstrong et al.
Lourdes M Perez-Chada et al.
The International Dermatology Outcome Measures is a nonprofit organization dedicated to developing evidence-based, patient-centered outcome measures for dermatologic conditions. At the 2018 Alopecia Areata Research Summit, Dr Gottlieb, Pres...
The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms [0.03%]
斑秃终点开发中患者的角色：理解物理迹象和症状
Kathleen W Wyrwich,Helen Kitchen,Sarah Knight et al.
Kathleen W Wyrwich et al.
Meaningful patient input to understand disease experience and patient expectations for improvement with treatment is essential for the selection and development of outcome measures for alopecia areata (AA) clinical trials. This study explor...
A Botanical Compound for the Treatment of Alopecia Areata and Chemotherapy-Induced Alopecia [0.03%]
治疗斑秃和化疗引起的脱发的植物化合物
Bruce Patsner,Saad Harti
Bruce Patsner
Legacy Healthcare has developed and patented a topical botanical with a unique mechanism of action, an extensive clinical data package, and excellent safety from the 2.2 million units already sold, all of which has enabled it to enter late-...
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study [0.03%]
斑秃的疾病负担：一项横断面在线调查研究
Natasha Mesinkovska,Brett King,Paradi Mirmirani et al.
Natasha Mesinkovska et al.
Previous QOL and disease burden studies have not captured all relevant aspects of living with alopecia areata (AA). To better understand the burden and everyday experience of living with moderate-to-severe AA, a cross-sectional, online, qua...
Jean-Phillip Okhovat,Tristan Grogan,Lewei Duan et al.
Jean-Phillip Okhovat et al.
A Potential Role for IL-4 and IL-13 in an Alopecia Areata-Like Phenotype: A Clinical Perspective [0.03%]
白发性状中IL-4和IL-13的潜在作用：临床视角
Dustin H Marks,Maryanne M Senna
Dustin H Marks
Although alopecia areata (AA) has been traditionally classified as a strictly T helper type 1-mediated process, the T helper type 2 (Th2) pathway may contribute to an AA-like phenotype in some individuals. Herein, we describe three clinical...
Teresa Song,Emma Guttman-Yassky
Teresa Song
Alopecia areata (AA) has been recently shown to also include T-helper cell type 2/IL-23 activation, in addition to T-helper cell type 1/IFN-skewing. The success of Jak inhibition together with IL-4Rα antagonism and limited response to IL-1...
Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A Case Series [0.03%]
光学相干断层扫描监测自体血小板丰富血浆治疗斑秃病患者的反应：病例报告
Chloe Ekelem,Margit Juhasz,Junxiao Yu et al.
Chloe Ekelem et al.
Alopecia areata (AA) is an autoimmune hair loss condition that is difficult to treat and frequently disruptive to the psychosocial well-being of patients. Platelet-rich plasma (PRP) is an innovative therapy that provides concentrated GFs th...